UK Health Secretary Wes Streeting has announced a plan to provide weight-loss injections to unemployed individuals diagnosed as obese, aiming to improve their health and boost the economy. This initiative is part of a £280m investment from Lilly, which will conduct trials on the drug Mounjaro's effects on productivity and health outcomes. Streeting highlights the economic burden of obesity, which costs the NHS £11bn annually and affects workforce participation. The first trial will take place in Greater Manchester, with hopes of advancing treatment for obesity. Teljes cikk (Euronews.com)